CASI
CASI Pharmaceuticals
CASI
CASI
Delisted
CASI was delisted on the 25th of February, 2026.
22 hedge funds and large institutions have $4.33M invested in CASI Pharmaceuticals in 2025 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
40% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 5
Holders
22
Holding in Top 10
–
Calls
$2K
Puts
–
Top Buyers
| 1 | +$433K | |
| 2 | +$344K | |
| 3 | +$59.4K | |
| 4 |
GSC
Ground Swell Capital
Folly Beach,
South Carolina
|
+$18.1K |
| 5 |
Renaissance Technologies
New York
|
+$8.38K |
Top Sellers
| 1 | -$52.1K | |
| 2 | -$42.8K | |
| 3 | -$38K | |
| 4 |
TSS
Two Sigma Securities
New York
|
-$13.7K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$12K |